Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Phase I oncology drug development
Timothy A. Yap
,
Jordi Rodon
, S. Hong David
Investigational Cancer Therapeutics
Research output
:
Book/Report
›
Book
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phase I oncology drug development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Drug Development
100%
Biomarkers
34%
Clinical Trials, Phase I
32%
Precision Medicine
28%
Hematology
28%
Neoplasms
25%
Antineoplastic Agents
25%
Industry
24%
Immunotherapy
23%
Patient Selection
23%
Pharmaceutical Preparations
21%
Pharmacokinetics
19%
Nurses
19%
Research Personnel
18%
Radiotherapy
18%
Clinical Trials
17%
Drug Therapy
15%
Therapeutics
12%
Health
12%